{'fraction_non_alphanumeric': 0.028985507246376812, 'fraction_numerical': 0.015458937198067632, 'mean_word_length': 4.954022988505747, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
DIABETES MELLITUS IN COVID-19 PATIENTS: VERDICT OR NOT?

OBJECTIVE
The aim: To investigate the causes of the negative impact of diabetes mellitus co-morbidity on the onset and development of COVID-19 in diabetic patients.


PATIENTS AND METHODS
Materials and methods: Electronic databases of MEDLINE and Google Scholar were searched using keyword searches.


CONCLUSION
Conclusions: 1. Diabetes mellitus is not a verdict. Diabetic patients can have COVID-19 with the same frequency as other people. And diabetes mellitus co-morbidity does not increase the probability of development COVID-19. 2. Previous diabetes can contribute the complications of COVID-19, patient's severe condition and can increase the mortality. 3. The reasons for the negative results of COVID 19 treatment in patients with diabetes may be: features of autonomic innervation in patients with diabetes, impaired function of pancreatic islet cells due to the influence of SARS-CoV-2, use of some cardiac drugs, expression of inflammatory factors due to infection.